Table 1B.
Alternative of viral vector-mediates gene transfection.
Non-virus | Capability | Delivery method | Benefit compare to viral vector-mediates gene transfection |
---|---|---|---|
Electroporation | >10 kb | – | Do not integrate/time saving/cost low |
Less toxicity/less immunity | |||
Higher efficiency/bigger capacity | |||
CATIONIC LIPID MEDIATES DELIVERY | |||
DNA | Unlimited | Longer duration | |
Stereotaxic injection | Higher mean level of expression per cell | ||
RNA | Unnecessary of transit across the nuclei membrane | ||
Onset of expression is faster than DNA | |||
Preferable in some clinical applications | |||
POLYETHYLENIMINE | |||
Unlimited | Bone-marrow derived macrophage system | Less cytotoxicity | |
Increased cellular uptake and stability | |||
Non-invasive imaging for tracking | |||
Ventricular delivery | |||
DENDRIGRAFTED POLY-L-LYSINE | |||
Unlimited | Ventricular delivery | Cross the BBB by specific receptor mediated transcytosis | |
Targeted nanoparticles could accumulate in brain more efficiently | |||
CHITOSAN WITH GRAFT WITH PEI | |||
Unlimited | Stereotaxic injection | Improved water solubility | |
Low toxicity | |||
High transfection efficiency |